shot-button
E-paper E-paper
Home > News > India News > Article > Manohar Parrikar responding well to treatment in US says Suresh Prabhu

Manohar Parrikar responding well to treatment in US, says Suresh Prabhu

Updated on: 24 March,2018 05:59 PM IST  |  Panaji
IANS |

Parrikar is suffering from advanced pancreatic cancer and was admitted to a New York hospital earlier this month

Manohar Parrikar responding well to treatment in US, says Suresh Prabhu

Manohar Parrikar responding well to treatment in US, says Suresh Prabhu


Manohar Parrikar. Pic/AFP


Panaji: Ailing Goa Chief Minister Manohar Parrikar is responding well to treatment in the US, Union Minister Suresh Prabhu said on Saturday.


"Spoke to @manoharparrikar who is responding well to treatment in the US. Hospital. Wished him speedy recovery, early return home to lead Goa," Prabhu said in in a tweet.

Parrikar is suffering from advanced pancreatic cancer and was admitted to a New York hospital earlier this month.

After being admitted to the Lilavati Hospital in Mumbai twice since February 15, he was flown to the US on March 7 for further treatment.

The Goa CMO has repeatedly maintained that Parrikar suffers from "mild pancreatitis".

Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK